|View printer-friendly version|
|Array CEO Robert E. Conway to Speak At UBS Warburg Global Life Sciences Conference|
|BOULDER, Colo., Sep 23, 2002 /PRNewswire-FirstCall via COMTEX/ -- Array
BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer,
Robert E. Conway, will speak at the UBS Warburg Global Life Sciences Conference
on October 8 in New York City. The public is welcome to participate in the
conference through an audio webcast on the UBS Warburg website.
Presentation by: Robert E. Conway, Chief Executive Officer, Array BioPharma
Date: Tuesday, October 8, 2002
Time: 8:30 a.m. Eastern Time
Location: The Plaza on Fifth Avenue at Central Park South, New York City
Audio Webcast: www.ubswarburg.com
To access the audio webcast, go to www.ubswarburg.com and click on the UBS Warburg conference link found on the lower right side of the page. Follow the link for Live Audio under the Global Life Sciences Conference heading. The presentation will be available live and by replay. The replay will begin three hours after the presentation time and will be available until November 10, 2002.
About Array BioPharma:
Array BioPharma is a drug discovery company creating new small molecule drugs through the integration of chemistry, biology and informatics. Our experienced scientists use our integrated set of drug discovery technologies, which we call the Array Discovery Platform, to invent small molecule drugs in collaboration with leading pharmaceutical and biotechnology companies and to build our own pipeline of proprietary drug candidates. For more information on Array BioPharma, please visit our web site at www.arraybiopharma.com .
SOURCE Array BioPharma Inc.
CONTACT: Tricia Haugeto of Array BioPharma Inc., +1-303-386-1193, email@example.com